P.M. Edition for May 31. The FDA approves Pfizer’s vaccine for RSV, a deadly respiratory virus. But as Wall Street Journal health business editor Jonathan Rockoff reports, companies are preparing to introduce the shots after resistance to vaccination reached new highs during the pandemic. Annmarie Fertoli hosts.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Drugmakers Face Ongoing Vaccine Hesitancy

What's News brings you the headlines and business news that move markets and the world—twice every weekday. In about 15 minutes, get caught up on the best Wall Street Journal scoops and exclusives, with insight and analysis from the award-winning reporters that broke the stories. Hosted by Annmarie Fertoli and Luke Vargas.

News

Daily News

P.M. Edition for April 22. The so-called Magnificent Seven stocks shed a combined $950 billion in market value last week, the largest on record. Wall Street Journal banking reporter Charley Grant says upcoming earnings offer an opportunity to stop the slide. And OpenAI CEO Sam Altman invests in a company tackling artificial intelligence’s big appetite for clean energy. Climate finance reporter Amrith Ramkumar has more. Plus, opening statements kick off Trump’s hush-money trial in Manhattan. Sabrina Siddiqui hosts.



Listening on Google Podcasts? Here's our guide for switching to a different podcast player.



Learn more about your ad choices. Visit megaphone.fm/adchoices

Big Tech Faces Earnings Test

A.M. Edition for April 22. The House over the weekend passed a $95 billion foreign aid-package, along with a bill that would force the sale of TikTok by its Chinese-controlled owner. WSJ congressional reporter Natalie Andrews explains how those measures are likely to fare in the Senate. Plus, reporter William Boston on the state of the car industry after VW workers vote to join the UAW and Tesla cuts prices. And the Supreme Court takes on homelessness. Luke Vargas hosts.



Listening on Google Podcasts? Here's our guide for switching to a different podcast player.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Ukraine Aid Bill, TikTok Ban Head to U.S. Senate

Tesla’s stock has fallen by about 40% this year. Last week, the company announced layoffs and a recall of its newest electric vehicle, the Cybertruck, due to a faulty accelerator pedal months after it was released. Other car makers are reporting weakened demand for EVs, and a lot more interest in hybrid cars from American consumers. So, what happened to the high hopes of America’s electric car future? WSJ’s Stephen Wilmot and Mike Colias answer listener questions on what’s going on in the EV market and what it means for consumers, investors and the automakers like General Motors, Ford and Toyota. Annmarie Fertoli hosts.



Further Reading

The Six Months That Short-Circuited the Electric-Vehicle Revolution

Biden’s EPA Gives Automakers More Leeway to Phase Out Gas-Engine Cars

Tesla Agrees to Settle Lawsuit Over Autopilot’s Involvement in 2018 Fatal Crash 

The Inside Tale of Tesla’s Fall to Earth 

How Electric Vehicles Are Losing Momentum with U.S. Buyers, in Charts 

Learn more about your ad choices. Visit megaphone.fm/adchoices

Tesla’s Troubles and the EV Slowdown: Your Questions Answered

How did United Airlines' earnings land with investors? And why are subscribers not enough for Netflix? Plus, what troubles Live Nation? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.

Learn more about your ad choices. Visit megaphone.fm/adchoices

What’s News in Markets: High Flier, Revenue Shift, Ticket Trouble

P.M. Edition for April 19. We end our series on inflation in Zimbabwe. The country recently launched a new currency, but will it help locals who struggle with inflation and can’t save? Producer Anthony Bansie reports. Plus, Tesla recalls 3,878 Cybertrucks to repair or replace faulty accelerator pedals. Annmarie Fertoli hosts.



Listening on Google Podcasts? Here's our guide for switching to a different podcast player.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Drugmakers Face Ongoing Vaccine Hesitancy

Download our free app to listen on your phone